Deep intronic point mutations of the KIT gene in a female patient with cutaneous clear cell sarcoma and her family

Cancer Genetics

Volumn 205, Issue 4, 2012, Pages 182-185

  Gambichler, Thilo ^a   Pantelaki, Ioanna ^a   Othlinghaus, Nick ^a   Moritz, Rose K C ^a   Stricker, Ingo ^a   Skrygan, Marina ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Clear cell sarcoma; EWSR1 ATF1 chimeric gene; Intronic point mutation; KIT gene; Malignant melanoma of soft parts

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD68 ANTIGEN; KI 67 ANTIGEN; MELAN A; PROTEIN S 100; VIMENTIN; ACTIVATING TRANSCRIPTION FACTOR 1; ATF1 PROTEIN, HUMAN; CALMODULIN BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; ONCOPROTEIN; RNA BINDING PROTEIN;

ADOLESCENT; ARTICLE; ATF1 GENE; CASE REPORT; CLEAR CELL SARCOMA; CLINICAL FEATURE; EWSR1 GENE; FEMALE; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; GENOMIC IN SITU HYBRIDIZATION; GERM LINE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTRON; KIT GENE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; ONCOGENE; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE BIOPSY; SEQUENCE ANALYSIS; SKIN CARCINOGENESIS; SKIN TUMOR; SPINDLE CELL; TUMOR GENE; GENETICS; MALE; MUTATION; PATHOLOGY;

ACTIVATING TRANSCRIPTION FACTOR 1; ADOLESCENT; CALMODULIN-BINDING PROTEINS; FEMALE; GENE FUSION; GERM-LINE MUTATION; HUMANS; INTRONS; MALE; ONCOGENE PROTEINS, FUSION; POINT MUTATION; RNA-BINDING PROTEINS; SARCOMA, CLEAR CELL; SKIN NEOPLASMS;

EID: 84862736329     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.02.001     Document Type: Article

References (15)

1. Kawai A., Hosono A., Nakayama R., et al. Clear cell sarcoma of tendons and aponeuroses. A study of 75 patients. Cancer 2007, 109:109-116.
2. Hantschke M., Mentzel T., Rütten A., et al. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol 2010, 34:216-222.
3. Song J.S., Choi J., Kim J.H., et al. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma. Pathol Int 2010, 60:608-613.
4. Wang W.L., Mayordomo E., Zhang W., et al. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol 2009, 22:1201-1209.
5. Garcia J.J., Kramer M.J., Mackey Z.B., O'Donnell R.J., Horvai A.E. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma. Arch Pathol Lab Med 2006, 130:343-348.
6. Panagopoulos I., Mertens F., Isaksson M., et al. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet 2005, 156:74-76.
7. Beadling C., Jacobson-Dunlop E., Hodi F.S., et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008, 14:6821-6828.
8. Harland M., Mistry S., Bishop D.T., et al. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet 2001, 10:2679-2686.
9. Coutinho G., Xie J., Du L., et al. Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a. Hum Mutat 2005, 25:118-124.
10. Sironi M., Menozzi G., Comi G.P., et al. Analysis of intronic conserved elements indicates that functional complexity might represent a major source of negative selection on non-coding sequences. Hum Mol Genet 2005, 14:2533-2546.
11. Huang P.Y., Hong M.H., Zhang X., et al. C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines. Chin J Cancer 2010, 29:131-135.
12. Chen L.L., Holden J.A., Choi H., et al. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 2008, 21:826-836.
13. Corless C.L., McGreevey L., Town A., et al. KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors. J Mol Diagn 2004, 6:366-370.
14. Ying S.Y., Lin S.L. Intron-derived microRNAs-fine tuning of gene functions. Gene 2004, 342:25-28.
15. Lin Z.H., Han E.M., Lee E.S., et al. A distinct expression pattern and point mutation of c-KIT in papillary renal cell carcinomas. Mod Pathol 2004, 17:611-616.